3ZFF
Human enterovirus 71 in complex with capsid binding inhibitor WIN51711
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 14-BM-C |
Synchrotron site | APS |
Beamline | 14-BM-C |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-04-01 |
Detector | ADSC QUANTUM 315 |
Spacegroup name | I 2 3 |
Unit cell lengths | 591.000, 591.000, 591.000 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 27.500 - 3.400 |
R-factor | 0.2434 |
Rwork | 0.243 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4aed |
RMSD bond length | 0.008 |
RMSD bond angle | 1.490 |
Data reduction software | HKL-2000 |
Data scaling software | SCALEPACK |
Phasing software | GLRF |
Refinement software | CNS (1.3) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 27.500 | 3.550 |
High resolution limit [Å] | 3.400 | 3.400 |
Rmerge | 0.250 | 0.540 |
Number of reflections | 247559 | |
<I/σ(I)> | 2.6 | 1.06 |
Completeness [%] | 53.3 | 27.5 |
Redundancy | 1.8 | 1.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 8.5 | THE CRYSTALLIZATION DROPS WERE PREPARED BY MIXING 0.83UL OF EV71 AT 2MG/ML IN PBS WITH 0.17UL OF 0.2M SODIUM CITRATE, 0.1M TRIS PH8.5, 30% V/V PEG 400. THE WELL SOLUTION CONTAINED 1.8M SODIUM ACETATE AND 0.1M BIS-TRIS PROPANE PH7.0. |